1H-Benzo[d][1,2,3]triazol-1-yl (2-(trimethylsilyl)ethyl) carbonate, 98%, 1g

3-BROMO-4,5,6,7-TETRAHYDROPYRAZOLO[1,5-A]PYRAZINE HCL, 95.0%, 1g

2-Amino-6-methylbenzoic acid, 98.0%, 10g

4-Cyanopyridine-N-oxide, 95.0%, 10g

Benzamidoxine, 98.0%, 25g

2,3-Dichloro-4-trifluoromethylpyridine, 95.0%, 5g

6-isopropyl-3-methyl-1-phenyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid, 95.0%, 250mg

tert-Butyl 3-hydroxycyclobutane-1-carboxylate, 98%, 250mg

Ethyl 4,7-dichloro-1H-indole-2-carboxylate, 97.0%, 250mg

4-Bromo-2-thiophenecarboxaldehyde, 98.0%, 100g

Ixazomib citrate, 98%, 250mg

éther tert-butylméthylique, min.99,5%, pour la synthèse, 1 l, emballage en verre

Diethyl 2-Bromo-2-methylmalonate>98.0%(GC)(T)25g